Maria Carell

Chief Executive Officer, Revision Skincare and Goodier  

As Chief Executive Officer and President of Revision Skincare and Goodier Cosmetics, Maria Carell is leading the brand’s growth through acquisitions and expansion into new markets around the globe, while helping build on its legacy of being first-to-market with innovative, science-driven, effective skincare. Maria has an extensive background in operating, acquiring, and developing healthcare and life science companies, focusing on pharmaceutical and medical device companies. She has served as CEO of Exeltis USA (part of the Chemo Group), as President of Meda Pharmaceuticals and Executive Vice President of MEDA AB (NASDAQ OMX, Large Cap), as CEO and President of Q-Med (NASDAQ OMX Mid Cap), and as General Manager of Actavis Pharmaceuticals. She has also served in several Business Development and Sales and Marketing roles for organizations ranging in size from small entrepreneurial to global multinational companies (Novartis, Johnson & Johnson).

Maria holds a master's degree in International Business/Business Administration from Linkoping University, Sweden.